Owkin Announces Partnership with Consensus to Strengthen Literature Intelligence for Owkin’s AI Scientist, K Pro
- Users of K Pro, Owkin’s AI Scientist for biology, will be able to access broad research coverage and generate answers grounded in 200M+ peer-reviewed scientific articles
Paris, France - March 3rd, 2026 - Owkin, an AI company on a mission to build biological artificial superintelligence to cure all disease, today announced a partnership with Consensus, the leading AI-powered research search engine, to bring enhanced scientific literature intelligence into Owkin’s AI Scientist for Biology, K Pro.
Through this partnership, K Pro users will be able to generate answers grounded in full‑text scientific articles - excluding redacted articles - with additional controls to refine results based on recency, citations, and journal reputation and impact. Consensus mitigates the risk of hallucination, guaranteeing every paper cited is real and every summary based on research.
The integration is designed to support more precise scientific research workflows, complementing Owkin’s expertise in multimodal analysis and data-driven biology.
Pascal Weinberger, Owkin's Co-CEO said:
“By combining Owkin’s agentic data driven approach to biological research with Consensus’s literature intelligence, we aim to help teams move faster from scientific question to evidence-based insight.”
Eric Olson, CEO of Consensus said:
“Consensus is focused on making research more trustworthy and usable at the point of decision. We’re excited to partner with Owkin to bring high-confidence literature intelligence into workflows that matter for biology and medicine.”
Press Contact: alistair.jennings@owkin.com
About Owkin
Owkin is an agentic AI company pioneering Biological Artificial Superintelligence to solve problems in biology where human researchers alone have failed.
Owkin builds K Pro - an AI scientist for pharmaceutical research and strategic decision-making. K Pro orchestrates a suite of AI skills and tools to decode complex biology, accelerate research, and dramatically increase productivity.
K Pro is built on Owkin’s unrivalled multimodal patient data network, state-of-the-art AI for biology and a decade of experience working with pharmaceutical partners.
